Cargando…
Creation of a Peptide Antagonist of the GFRAL–RET Receptor Complex for the Treatment of GDF15-Induced Malaise
[Image: see text] Growth differentiation factor 15 (GDF15) is a contributor to nausea, emesis, and anorexia following chemotherapy via binding to the GFRAL-RET receptor complex expressed in hindbrain neurons. Therefore, GDF15-mediated GFRAL-RET signaling is a promising target for improving treatment...
Autores principales: | Borner, Tito, Tinsley, Ian C., Milliken, Brandon T., Doebley, Sarah A., Najjar, Nicholas R., Kerwood, Deborah J., De Jonghe, Bart C., Hayes, Matthew R., Doyle, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461225/ https://www.ncbi.nlm.nih.gov/pubmed/37506293 http://dx.doi.org/10.1021/acs.jmedchem.3c00667 |
Ejemplares similares
-
Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer
por: Buchholz, Karolina, et al.
Publicado: (2021) -
Targeting both sides of the GDF15-GFRAL-RET receptor complex: A new approach to achieve body weight homeostasis
por: Li, Fei, et al.
Publicado: (2017) -
Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons
por: Boccia, Lavinia, et al.
Publicado: (2022) -
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer
por: Ahmed, Darakhshan Sohail, et al.
Publicado: (2021) -
Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment
por: Reiner, Benjamin C., et al.
Publicado: (2021)